BlackRock Inc. - PYXIS ONCOLOGY INC ownership

PYXIS ONCOLOGY INC's ticker is and the CUSIP is 747324101. A total of 40 filers reported holding PYXIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of PYXIS ONCOLOGY INC
ValueSharesWeighting
Q3 2023$600,013
-12.7%
301,514
+12.3%
0.00%
Q2 2023$687,199
-19.3%
268,437
+26.4%
0.00%
Q1 2023$851,275
+200.6%
212,288
+0.5%
0.00%
Q4 2022$283,184
-30.3%
211,332
+2.3%
0.00%
Q3 2022$406,000
-17.0%
206,554
+0.6%
0.00%
Q2 2022$489,000
-76.8%
205,304
-60.6%
0.00%
Q1 2022$2,104,000
-62.7%
520,901
+1.4%
0.00%
Q4 2021$5,637,000513,8480.00%
Other shareholders
PYXIS ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Yu Fan 69,303$137,9129.78%
Decheng Capital Management III (Cayman), LLC 326,810$650,3520.22%
Harvest Investment Services, LLC 113,894$226,6490.15%
Laurion Capital Management LP 3,170,803$6,309,8980.04%
CORNERCAP INVESTMENT COUNSEL INC 74,903$149,0570.03%
SCHULHOFF & CO INC 22,000$43,7800.02%
HHLR ADVISORS, LTD. 382,606$761,3860.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 236,195$470,0280.01%
ExodusPoint Capital Management, LP 415,072$8260.01%
Bleakley Financial Group, LLC 11,234$22,3560.00%
View complete list of PYXIS ONCOLOGY INC shareholders